KIMBERLY PINCKNEY: Open Payments
NPI 1134328941 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 26 payments from 19 companies in 2025. Trend: 2023 $465 · 2024 $291 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $200 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Madrigal Pharmaceuticals | 1 | $36 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Recor Medical Inc | 1 | $34 |
| Novo Nordisk Inc | 1 | $31 |
| Lilly USA, LLC | 2 | $31 |
| Exact Sciences Corporation | 1 | $30 |
| CooperSurgical, Inc. | 1 | $26 |
Products named: REPATHA, OTEZLA, AIRSUPRA, GEMTESA, REZDIFFRA, Symbravo, Paradise Ultrasound Renal Denervation System, Wegovy.
Industry payments across CA — which companies pay providers there.
